Collateral for a security interest recorded Jan 30, 2026 (Wilmington Trust, National Association).
Term ends Apr 12, 2027 · High confidence
20-year base term ended Nov 1, 2026
Held by HR Pharmaceuticals, Inc.
Filed Nov 1, 2006 as application 11/555,307 · Granted Dec 2, 2008
Base term plus 162 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
Nov 1, 2006
Nov 1, 2006
Term ends
Apr 12, 2027
Apr 12, 2027
Granted
Dec 2, 2008
Dec 2, 2008
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
162
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 162 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 1, 2006, when this application, 11/555,307, was filed | Nov 1, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +162 days, USPTO patent term adjustment record | Apr 12, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force (reinstated) | High confidence |
| Computed term end | The steps above, in order | Apr 12, 2027 | High confidence |
This family
| US 7,632,256 | Term ended Nov 2026 | Nov 2026 |
| US 7,458,964 | this patent Apr 2027 | Apr 2027 |
| US 7,985,217 | In force Sep 2027 | Sep 2027 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 28, 2006 Reel 18557, frame 972 | Mosler, Theodore J.; Korogi, Todd M.; Jarnagin, Scott P.; Hiltz, F. Peter; Golden, John H. | Medical Technology of Georgia, LLC | Assignment of Assignor's Interest |
| Nov 7, 2007 Reel 20080, frame 267 | Mosler, Theodore J.; Korogi, Todd M.; Jarnagin, Scott P.; Hiltz, F. Peter; Golden, John H. | Medical Technologies of Georgia, Inc. | Corrective Assignment to Correct the Receving Party Data Previously Recorded on Reel 018557 Frame 0972. Assignor(S) Hereby Confirms the Medical Technology of Georgia, LLC. |
| Jan 6, 2022 Reel 58575, frame 323 | Wiesman Holdings, LLC | Ttga SBIC Pioneer Fund I, LP | Security Interest |
| Feb 8, 2022 Reel 58965, frame 787 | Medical Technologies of Georgia, Inc.; Medical Technologies of Georgia, LLC | Medical Technologies of Georgia, LLC | Merger and Change of Name |
| Sep 16, 2022 Reel 61116, frame 968 | Medical Technologies of Georgia, Inc. | HR Pharmeceuticals, Inc. | Assignment of Assignor's Interest |
| Sep 16, 2022 Reel 61117, frame 13 | HR Pharmeceuticals, Inc. | Wiesman Holdings, LLC | Assignment of Assignor's Interest |
| Oct 7, 2022 Reel 61623, frame 942 | HR Pharmaceuticals, Inc. | Wiesman Holdings, LLC | Corrective Assignment to Correct the the Assignor Name Previously Recorded at Reel: 061117 Frame: 0013. Assignor(S) Hereby Confirms the Assignment. |
| Oct 7, 2022 Reel 61623, frame 994 | Medical Technologies of Georgia, Inc. | HR Pharmaceuticals, Inc. | Corrective Assignment to Correct the Assignee Is HR Pharmaceuticals, Inc. Previously Recorded at Reel: 061116 Frame: 0968. Assignor(S) Hereby Confirms the Assignment. |
| Jun 30, 2023 Reel 64124, frame 342 | Wiesman Holdings, LLC | Pnc Bank, National Association | Security Interest |
| Oct 8, 2025 Reel 73055, frame 829 | Medical Technologies of Georgia, LLC | HR Pharmaceuticals, Inc. | Confirmatory Assignment |
| Jan 30, 2026 Reel 73646, frame 851 | Wiesman Holdings, LLC; HR Pharmaceuticals LLC | Wilmington Trust, National Association | Security Interest |
| Jul 22, 2026 Reel 76136, frame 296 | Wiesman Holdings, LLC; HR Pharmaceuticals LLC | Wilmington Trust, National Association | Corrective Assignment to Correct the Owners' Names as Listed in the Schedule to the Agreement Previously Recorded on Reel 73646 Frame 851. Assignor(S) Hereby Confirms the Grant of a Security Interest to Wilmington Trust, National Association. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2027
Term ends Apr 12, 2027. No further fees fall due before then
Note
The 162 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
64
later US patents cite this one
That is top 25% of utility patents granted in 2008 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.